Moreover, Matsuda et al. have shown that the SGLT2 inhibitor (SGLT2i) dapagliflozin mitigated oxidative stress and reduced inflammatory response in a rabbit model of cardiac surgery-associated acute kidney injury [67]. Here, SLC5A2 is linked to acute kidney injury.